Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern.
作者信息
Park Sun Hee
机构信息
Division of Infectious Diseases, Department of Internal Medicine, Daejeon St. Mary's Hospital, The Catholic University of Korea College of Medicine, Daejeon, Korea.
出版信息
Korean J Intern Med. 2014 Jan;29(1):27-30. doi: 10.3904/kjim.2014.29.1.27. Epub 2014 Jan 2.
Abstract
摘要
相似文献
1
Third-generation cephalosporin resistance in gram-negative bacteria in the community: a growing public health concern.
Korean J Intern Med. 2014 Jan;29(1):27-30. doi: 10.3904/kjim.2014.29.1.27. Epub 2014 Jan 2.
2
Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
Korean J Intern Med. 2014 Jan;29(1):49-56. doi: 10.3904/kjim.2014.29.1.49. Epub 2014 Jan 2.
3
Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Int J Infect Dis. 2010 Sep;14 Suppl 3:e171-5. doi: 10.1016/j.ijid.2010.01.004. Epub 2010 May 14.
4
[Risk factors and prognosis in 31 patients with extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae bloodstream infection].
Zhonghua Jie He He Hu Xi Za Zhi. 2008 Nov;31(11):815-9.
5
Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.
BMC Infect Dis. 2008 Sep 15;8:116. doi: 10.1186/1471-2334-8-116.
6
Nosocomial bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae resistant to third-generation cephalosporins, Finland, 1999-2013: Trends, patient characteristics and mortality.
Infect Dis (Lond). 2016;48(3):229-34. doi: 10.3109/23744235.2015.1109135. Epub 2015 Nov 18.
7
Mortality risk of bloodstream infection caused by either Escherichia coli or Klebsiella pneumoniae producing extended-spectrum β-lactamase: a prospective cohort study.
BMC Res Notes. 2019 Nov 1;12(1):719. doi: 10.1186/s13104-019-4751-9.
8
Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Front Cell Infect Microbiol. 2015 Feb 12;5:11. doi: 10.3389/fcimb.2015.00011. eCollection 2015.
9
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
PLoS One. 2020 Jun 9;15(6):e0233704. doi: 10.1371/journal.pone.0233704. eCollection 2020.
10
Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media.
PLoS One. 2014 Dec 3;9(12):e114242. doi: 10.1371/journal.pone.0114242. eCollection 2014.
引用本文的文献
1
Ligand-based discovery of novel N-arylpyrrole derivatives as broad-spectrum antimicrobial agents with antibiofilm and anti-virulence activity.
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2523970. doi: 10.1080/14756366.2025.2523970. Epub 2025 Jul 8.
2
Molecular characterization of Staphylococcus aureus isolated from hospital-acquired infections in Ilam, Iran.
Mol Biol Rep. 2024 May 25;51(1):686. doi: 10.1007/s11033-024-09580-9.
3
Antibiotic Use in Hospital Urinary Tract Infections After FDA Regulation.
J Gen Intern Med. 2024 Jun;39(8):1414-1422. doi: 10.1007/s11606-023-08559-9. Epub 2023 Dec 26.
4
Photoinduced behaviour of N,N-bidentate manganese(I) and rhenium(I) tricarbonyl complexes for singlet oxygen generation and CO release.
Photochem Photobiol Sci. 2024 Jan;23(1):119-132. doi: 10.1007/s43630-023-00507-0. Epub 2023 Dec 11.
5
Advancing Nanoscale Science: Synthesis and Bioprinting of Zeolitic Imidazole Framework-8 for Enhanced Anti-Infectious Therapeutic Efficacies.
Biomedicines. 2023 Oct 18;11(10):2832. doi: 10.3390/biomedicines11102832.
6
Clinically Isolated β-Lactam-Resistant Gram-Negative Bacilli in a Philippine Tertiary Care Hospital Harbor Multi-Class β-Lactamase Genes.
Pathogens. 2023 Aug 8;12(8):1019. doi: 10.3390/pathogens12081019.
7
Oxazolidinones as versatile scaffolds in medicinal chemistry.
RSC Med Chem. 2023 Feb 8;14(5):823-847. doi: 10.1039/d2md00415a. eCollection 2023 May 25.
8
Phenotypic and genotypic antibiotic susceptibility profiles of Gram-negative bacteria isolated from bloodstream infections at a referral hospital, Lusaka, Zambia.
PLOS Glob Public Health. 2023 Jan 31;3(1):e0001414. doi: 10.1371/journal.pgph.0001414. eCollection 2023.
9
Application of Plant-Derived Nanoparticles (PDNP) in Food-Producing Animals as a Bio-Control Agent against Antimicrobial-Resistant Pathogens.
Biomedicines. 2022 Sep 28;10(10):2426. doi: 10.3390/biomedicines10102426.
10
The Resistance Patterns in Isolates among Apparently Healthy Adults and Local Drivers of Antimicrobial Resistance: A Mixed-Methods Study in a Suburban Area of Nepal.
Trop Med Infect Dis. 2022 Jul 12;7(7):133. doi: 10.3390/tropicalmed7070133.
本文引用的文献
1
Third-generation cephalosporin resistance of community-onset Escherichia coli and Klebsiella pneumoniae bacteremia in a secondary hospital.
Korean J Intern Med. 2014 Jan;29(1):49-56. doi: 10.3904/kjim.2014.29.1.49. Epub 2014 Jan 2.
2
Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
J Korean Med Sci. 2013 Jul;28(7):998-1004. doi: 10.3346/jkms.2013.28.7.998. Epub 2013 Jul 3.
3
Epidemiology, microbiology and mortality associated with community-acquired bacteremia in northeast Thailand: a multicenter surveillance study.
PLoS One. 2013;8(1):e54714. doi: 10.1371/journal.pone.0054714. Epub 2013 Jan 18.
4
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis.
J Antimicrob Chemother. 2012 Dec;67(12):2793-803. doi: 10.1093/jac/dks301. Epub 2012 Aug 21.
5
Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
BMC Infect Dis. 2012 Jun 29;12:149. doi: 10.1186/1471-2334-12-149.
6
β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts.
Clin Infect Dis. 2012 Jan 15;54(2):167-74. doi: 10.1093/cid/cir790. Epub 2011 Nov 4.
7
Emergence of extended-spectrum β-lactamase-producing escherichia coli as a cause of community-onset bacteremia in South Korea: risk factors and clinical outcomes.
Microb Drug Resist. 2011 Dec;17(4):537-44. doi: 10.1089/mdr.2011.0072. Epub 2011 Aug 29.
8
Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae.
Microb Drug Resist. 2011 Jun;17(2):267-73. doi: 10.1089/mdr.2010.0134. Epub 2011 Mar 9.
9
Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase-producing Escherichia coli.
Int J Antimicrob Agents. 2010 Sep;36(3):284-7. doi: 10.1016/j.ijantimicag.2010.05.009. Epub 2010 Jun 30.
10
Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern.
Lancet Infect Dis. 2008 Mar;8(3):159-66. doi: 10.1016/S1473-3099(08)70041-0.
Zotero 插件